MG
HCAT icon

Michael Gelband’s Health Catalyst HCAT Stock Holding History

Michael Gelband’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-97,117
Closed -$440K – 1665
2025
Q1 		$440K Buy
97,117
+82,003
+543% +$434K ﹤0.01% 1139
2024
Q4 		$107K Buy
+15,114
New +$120K ﹤0.01% 1402
2024
Q3 		– Sell
-21,806
Closed -$139K – 1797
2024
Q2 		$139K Sell
21,806
-45,328
-68% -$291K ﹤0.01% 1414
2024
Q1 		$506K Buy
67,134
+9,644
+17% +$88K ﹤0.01% 1136
2023
Q4 		$532K Sell
57,490
-10,707
-16% -$87.5K ﹤0.01% 1016
2023
Q3 		$690K Buy
68,197
+2,670
+4% +$31.9K 0.01% 1116
2023
Q2 		$819K Sell
65,527
-148,176
-69% -$1.76M 0.01% 1178
2023
Q1 		$2.49M Buy
213,703
+61,124
+40% +$779K 0.02% 794
2022
Q4 		$1.62M Buy
152,579
+11,588
+8% +$112K 0.02% 739
2022
Q3 		$1.37M Buy
140,991
+111,741
+382% +$1.48M 0.02% 967
2022
Q2 		$424K Sell
29,250
-38,674
-57% -$659K 0.01% 1419
2022
Q1 		$1.77M Buy
67,924
+49,305
+265% +$1.4M 0.02% 842
2021
Q4 		$738K Buy
18,619
+6,016
+48% +$274K 0.01% 1227
2021
Q3 		$630K Buy
+12,603
New +$687K 0.01% 1262
2020
Q3 		– Sell
-9,195
Closed -$268K – 1939
2020
Q2 		$268K Buy
9,195
+1,177
+15% +$32.5K 0.01% 1371
2020
Q1 		$210K Buy
+8,018
New +$245K 0.01% 770

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's HCAT Position: Q2 2025 in Review

Michael Gelband sold out of Health Catalyst (HCAT) in Q2 2025, closing a stake of 97,117 shares — an estimated $440K sold.

Michael Gelband first reported a position in HCAT in Q1 2020 and held it in 16 quarters. The position peaked at $2.49M in Q1 2023. 145 funds tracked by Wall St. Rank hold HCAT as of Q2 2025.

  • Michael Gelband reported no remaining Health Catalyst position as of Q2 2025 after selling out during the quarter.
  • Michael Gelband sold 97,117 Health Catalyst shares in Q2 2025, an estimated $440K.
  • Michael Gelband first reported a position in Health Catalyst in Q1 2020 and held it in 16 quarters.
  • Michael Gelband's Health Catalyst position peaked at $2.49M in Q1 2023.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.